Hormonal IUD (Mirena/Kyleena): How to Safely Stop

What the Levonorgestrel IUD Actually Does, and Why Stopping Matters

The Mirena and Kyleena devices release levonorgestrel (LNG) locally into the uterine cavity. Mirena releases approximately 20 mcg per day initially, declining to about 10 mcg per day by year five. Kyleena starts at roughly 17.5 mcg per day and falls to about 7.4 mcg per day by year five. Both are dramatically lower than oral progestin doses.

The mechanism is primarily local. LNG thickens cervical mucus, suppresses endometrial growth, and may inhibit sperm motility. Systemic absorption does occur, and serum LNG levels average around 150-200 pg/mL with Mirena, which is enough to cause systemic progestogenic effects in some women, including mood changes, acne flares, and libido shifts.

Stopping matters because the body has adapted. Ovarian follicular activity, which is partially suppressed in some users, resumes quickly after removal. The endometrium, which has been atrophied by continuous local LNG exposure, begins to regenerate. Women with PCOS, endometriosis, fibroids, or a history of heavy menstrual bleeding (HMB) need specific plans for what comes next.

How Mirena and Kyleena Differ at Discontinuation

The higher-dose Mirena is more likely to have produced amenorrhea (roughly 20% of users are amenorrheic by year one). When Mirena is removed, the return of menstruation can feel abrupt. Kyleena users are less often amenorrheic and may notice a smaller perceptual change. Neither device causes dependence in a pharmacological sense, but the hormonal shift is real and worth preparing for.

Why Women Stop

Women discontinue for several reasons: planned pregnancy, desire for hormone-free contraception, device expiration, side effects, or reaching menopause. Each reason carries a different clinical consideration, addressed below by life stage.

The Removal Procedure: What Actually Happens

Removal is an in-office procedure requiring no anesthetic in most cases. Your clinician uses a speculum, identifies the IUD strings at the cervical os, and applies gentle traction. The flexible arms of the T-frame fold upward as the device passes through the cervix.

Duration and Discomfort

Most removals take under two minutes from speculum insertion to device retrieval. The most common sensation is a brief cramping during cervical traction, similar to the pinch of a Pap smear. Women with cervical stenosis (more common after menopause or after certain uterine procedures) may experience more discomfort. Taking 400-600 mg of ibuprofen 30-60 minutes before the appointment is reasonable, though evidence that NSAIDs substantially reduce IUD removal pain is mixed.

Strings Not Visible: What Happens Next

If the strings have retracted into the uterine cavity (which happens in a small percentage of cases due to string breakage or uterine positioning), ultrasound guidance or a small instrument called a string retrieval hook may be needed. This is more involved but remains an outpatient procedure. Hysteroscopic removal is reserved for cases where the device is embedded.

Timing of Removal in the Cycle

There is no medically required timing for removal. If you are not planning an immediate pregnancy and want to avoid conception in the periremoval window, some clinicians recommend having a backup contraceptive method in place before removal day, since ovulation can return faster than many women expect.

Fertility Return After Hormonal IUD Removal

Fertility returns quickly. This is one of the clearest advantages of IUD discontinuation over hormonal pills or injectables.

A 2018 prospective study published in Contraception found that among women who removed LNG-IUDs to conceive, cumulative pregnancy rates at 12 months were comparable to those of women discontinuing copper IUDs or no contraception, suggesting the device leaves no lasting effect on fertility. Ovulation typically resumes within two to six weeks of removal.

By Life Stage: Reproductive Years

If you are under 35 and ovulatory before device insertion, expect your cycle to resume within one to three months. The first one or two cycles may be irregular as the endometrium regenerates and ovarian follicular activity normalizes. This irregularity is not a sign that fertility is impaired.

By Life Stage: Women Over 35 Trying to Conceive

Age-related egg quantity and quality decline regardless of IUD use. The IUD does not accelerate ovarian aging. If you are 35 or older and removing the IUD to conceive, ASRM guidelines recommend proceeding to fertility evaluation if pregnancy has not occurred within six months, rather than the usual 12-month wait applied to younger women.

By Life Stage: Perimenopause

Women in perimenopause who are using Mirena for endometrial protection during systemic estrogen therapy face a different question: when is it safe to remove the device without increasing endometrial cancer risk? The device provides the progestogenic component of combined HRT. Removing it while continuing systemic estrogen without replacing the progestogen is not safe for women with a uterus. The IUD's progestogenic effect on the endometrium wanes over approximately five years, which is why timely replacement or substitution matters in this group.

Hormone Changes After Removal: The "Mirena Crash" Explained

The term "Mirena crash" is not a medical diagnosis, but the experience it describes is real for some women. After years of low-level systemic LNG exposure, removal can trigger a transient drop in circulating progestin. This may produce symptoms including mood dips, irritability, breast tenderness, bloating, and fatigue in the days to weeks that follow.

The following framework helps distinguish expected hormonal recalibration from symptoms that warrant clinical attention:

Expected recalibration (no intervention required):

• Mood fluctuations lasting fewer than four weeks
• Breast tenderness in the first one to two cycles
• Spotting or irregular bleeding in the first two to three cycles
• Mild fatigue in the first two weeks

Symptoms that warrant a call to your clinician:

• Severe or worsening depressive symptoms
• No menstrual period by week 12 post-removal
• Pelvic pain escalating after removal (possible endometriosis flare)
• Acne flares that do not begin improving by week eight

The evidence base specifically for "Mirena crash" as a discrete syndrome is thin. Women have been historically underrepresented in IUD discontinuation research, and most data are derived from contraceptive trials that tracked pregnancy outcomes rather than hormonal symptom profiles. What we do have are observational reports and pharmacokinetic modeling. The honest answer is that we do not yet have randomized trial data characterizing this withdrawal pattern rigorously in women.

PCOS and Hormonal IUD Removal

Women with PCOS who used the IUD to manage irregular cycles or hormonal acne may see both return after removal. LNG suppresses endometrial buildup, which is protective in PCOS. After removal, if cycles remain anovulatory and the endometrium is not being shed regularly, ACOG recommends progestogen withdrawal bleeds every three months at minimum to reduce endometrial hyperplasia risk. Discuss a post-removal management plan with your clinician before the appointment.

Endometriosis and Removal

LNG-IUS suppresses endometrial lesion activity and dramatically reduces dysmenorrhea in many women with endometriosis. A Cochrane review found LNG-IUS significantly reduced pain scores compared with placebo or expectant management. After removal, pain may return within one to three cycles as lesion activity resumes. A plan for alternative suppressive therapy before removal day is worth arranging.

Heavy Menstrual Bleeding: What Returns After Removal

The landmark NEJM 2013 trial by Gupta et al. Demonstrated that LNG-IUS reduced heavy menstrual bleeding more effectively than usual care (including tranexamic acid, mefenamic acid, and combined oral contraceptives), with significantly greater improvement in health-related quality of life scores at two years. Women who used Mirena specifically for HMB can expect bleeding to return toward their pre-insertion baseline once the device is removed.

This is not automatic failure. For some women, underlying causes of HMB (fibroids, adenomyosis, ovulatory dysfunction) may have been partially managed independently during the years of IUD use. For others, the full pre-treatment HMB pattern will return within two to three cycles. Either way, having a next-step plan before removal protects quality of life.

Options to discuss with your clinician before removal:

• Tranexamic acid 1 g three times daily during heavy flow days
• Combined oral contraceptive pill if contraception is also wanted
• Norethindrone acetate for cycle regulation
• Evaluation for fibroids or adenomyosis if not recently performed
• Surgical options if HMB is refractory

Pregnancy and Lactation Safety

Pregnancy while the IUD is in place:

If pregnancy occurs with a Mirena or Kyleena in situ (which is rare but possible, with a failure rate of approximately 0.1-0.2% per year), the risk of ectopic pregnancy, septic abortion, and preterm labor increases significantly if the device is left in place. ACOG recommends removal of the IUD as early as possible in pregnancy if the strings are visible, even though removal itself carries some risk of miscarriage. If strings are not visible and removal would require instrumentation, the risks and benefits must be weighed individually with a specialist.

Levonorgestrel is a progestin with androgenic properties. There are theoretical concerns about virilization of a female fetus with systemic progestin exposure, but the systemic doses from LNG-IUS are very low. The label carries a warning, and any pregnancy with an IUD in situ should be managed in consultation with maternal-fetal medicine.

After removal with intent to conceive:

No washout period is needed. Conception may occur in the first ovulation cycle after removal. There is no evidence that prior LNG-IUS use increases miscarriage risk or congenital anomaly rates in subsequent pregnancies.

Lactation:

Mirena is frequently used postpartum and during breastfeeding. LNG transfer into breast milk is low. WHO Medical Eligibility Criteria classifies LNG-IUD as Category 1 (no restriction) for breastfeeding women after six weeks postpartum. After removal, there is no specific lactation concern; the small systemic LNG burden dissipates rapidly.

Contraception after removal:

If you are removing the IUD and do not want to conceive, contraception must be started on or before removal day. Ovulation can occur within days. No hormonal method requires a delay after IUD removal; you can start a combined pill, progestin-only pill, or patch on the day of removal. A copper IUD can be inserted at the same visit as Mirena or Kyleena removal.

Who This Is Right for, and Who Should Think Twice

Good candidates for IUD removal now

• You have completed your family or are ready to try to conceive.
• Your device has reached or is near its approved duration (five years for Kyleena, eight years for Mirena for contraception).
• You are experiencing side effects attributed to systemic LNG and have confirmed this with your clinician after ruling out other causes.
• You are post-menopausal and no longer need endometrial protection (requires FSH confirmation in the absence of a uterus-intact HRT discussion).

Situations where removal timing deserves more planning

• Active heavy menstrual bleeding with no alternative plan. Removing Mirena without a next step in place for HMB management risks a return to the bleeding severity that affected your quality of life before insertion.
• Endometriosis without suppressive backup. Coordinate a next-step therapy with your gynecologist or reproductive endocrinologist before the appointment.
• Perimenopause on systemic estrogen therapy. Mirena may be providing your only progestogenic endometrial protection. If you remove it without a progestogen substitute, you are exposing an intact endometrium to unopposed estrogen, which increases the risk of endometrial hyperplasia and cancer. Plan a progestogen bridge before removal.
• Strings not palpable or visible. Do not attempt self-removal. This is a clinical procedure requiring ultrasound confirmation of position and possibly hysteroscopic retrieval.

Framing by life stage

| Life Stage | Primary Consideration at Removal | |---|---| | Reproductive years, no pregnancy plan | Start alternate contraception on removal day | | Trying to conceive | No washout; expect ovulation within 2-6 weeks | | Over 35, TTC | Begin fertility evaluation at 6 months if not pregnant | | Postpartum | Confirm strings visible; lactation is not a contraindication to removal | | Perimenopause | Confirm progestogen replacement before removing if on systemic estrogen | | Post-menopause | Removal is safe; FSH >30 IU/L on two occasions >6 weeks apart supports menopause confirmation |

Practical Steps Before, During, and After Removal

Before the appointment

1. Confirm whether you can see or feel your strings (this is optional self-check information; do not pull them).
2. Take 400-600 mg ibuprofen 30-60 minutes before if you are sensitive to cramping.
3. If you have a history of vasovagal episodes during pelvic exams, inform the clinic. Lying flat for 10-15 minutes post-procedure is advisable.
4. If removing to conceive, begin prenatal folic acid 400-800 mcg daily before removal day.
5. If you have an STI risk or symptoms, get tested. Removal during active pelvic inflammatory disease is generally deferred or combined with antibiotic treatment.

The day of removal

• The appointment typically takes 15-30 minutes total including intake.
• Expect mild cramping for one to four hours afterward.
• Light spotting for one to three days is normal.
• You can drive yourself home in most cases; bring a heating pad if you want comfort for the ride.

After removal: the first three months

• Track your cycles with a period app or basal body temperature to assess ovulation return.
• If you had amenorrhea on Mirena, do not panic if your first period takes six to eight weeks to arrive.
• If no period by week 12, take a pregnancy test and contact your clinician.
• Return to your baseline gynecologic care schedule; removal does not require a follow-up appointment unless symptoms arise.

Sex-Specific Physiology: Why This Is Different for Women

Levonorgestrel has androgenic receptor affinity, which means it competes weakly at androgen receptors. In susceptible women, particularly those with pre-existing androgen sensitivity (common in PCOS), even the low systemic LNG dose from an IUD may contribute to acne, oily skin, or mood changes. After removal, serum LNG becomes undetectable within approximately 48 hours, and androgen-receptor competition from exogenous progestin resolves. Androgenic acne may paradoxically worsen transiently as the androgen-receptor space is unoccupied, before improving.

The menstrual cycle's own hormonal architecture, specifically the mid-luteal phase progesterone rise and estrogen fluctuation, resumes its full amplitude once endogenous ovulation returns. Women with a history of premenstrual dysphoric disorder (PMDD) should be aware that their PMDD may reassert itself after removal, since the flat progestin environment of the IUD may have been partially suppressing cyclical progesterone-driven GABA receptor changes. This is an area where women's physiology research is genuinely sparse. If you have a PMDD history, discuss pre-emptive management with your clinician before the device comes out.